Restoration of defective cross-presentation in tumors by gemcitabine
Tools
Tools
Tools
McDonnell, A.M, Joost Lesterhuis, W., Khong, A., Nowak, A.K, Lake, R.A., Currie, A.J. and Robinson, B.W.S. (2015) Restoration of defective cross-presentation in tumors by gemcitabine. OncoImmunology, 4 (5).
![[img]](https://researchrepository.murdoch.edu.au/style/images/fileicons/application_pdf.png)
Preview |
PDF
- Published Version
Available under License Creative Commons Attribution Non-commercial.
Download (130kB)
Available under License Creative Commons Attribution Non-commercial.
Download (130kB)
Free to read: http://dx.doi.org/10.1080/2162402X.2015.1005501
*No subscription required
*No subscription required
Abstract
Tumor antigen cross-presentation by dendritic cells (DCs) to specific CD8(+) T cells is central to antitumor immunity. Although highly efficient in draining lymph nodes, it is defective within the tumor site itself. Importantly, an immunogenic chemotherapy, gemcitabine, reverses this defect, allowing the potential re-stimulation of cytotoxic T lymphocytes within tumor sites.
| Item Type: | Journal Article |
|---|---|
| Murdoch Affiliation: | School of Veterinary and Life Sciences |
| Publisher: | Taylor & Francis |
| Copyright: | © The Authors |
| URI: | http://researchrepository.murdoch.edu.au/id/eprint/27226 |
 |
Item Control Page |
Downloads
Downloads per month over past year
